SEC Form 4 · accession 0001144204-17-057351
Fortress Biotech, Inc. · FBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lindsay A Rosenwald M.D.
Officer — PRESIDENT, CEO · Director · 10% Owner
Period of report
Nov 6, 2017
Accepted (ET)
Nov 8, 2017 · 6:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001429260
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| SERIES A CUMULATIVE REDEEMABLE PERPETUAL PREFERRED STOCK | Nov 6, 2017 | P | 40,000 | $25.00 | A | 40,000 | D |
Table II — derivative securities
No Table II lines on this filing.